✦ LIBER ✦

Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002

✍ Scribed by Maki, R. G.; Wathen, J. K.; Patel, S. R.; Priebat, D. A.; Okuno, S. H.; Samuels, B.; Fanucchi, M.; Harmon, D. C.; Schuetze, S. M.; Reinke, D.; Thall, P. F.; Benjamin, R. S.; Baker, L. H.; Hensley, M. L.

Book ID: 125496896
Publisher: American Society of Clinical Oncology
Year: 2007
Tongue: English
Weight: 163 KB
Volume: 25
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2006.10.4117

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Study of Sequential Gemcitabine

Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Alliance for Research Through Collaboration Study 003

✍ Fox, E.; Patel, S.; Wathen, J. K.; Schuetze, S.; Chawla, S.; Harmon, D.; Reinke, 📂 Article 📅 2012 🏛 Alphamed Press 🌐 English ⚖ 249 KB

Phase II study with the combination of g

Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas

✍ R. Losa; J. Fra; A. López-Pousa; M. Sierra; A. Goitia; E. Uña; R. Nadal; J. Garc 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 402 KB

Phase II study of weekly docetaxel and f

Phase II study of weekly docetaxel and fixed dose rate gemcitabine in patients with previously treated advanced soft tissue and bone sarcoma

✍ Eun Mi Lee; Sun Young Rha; Jeeyun Lee; Kyong Hwa Park; Jin-Hee Ahn 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 224 KB

A Randomized Phase II/III Trial of Perio

A Randomized Phase II/III Trial of Perioperative Chemotherapy with Adriamycin Plus Ifosfamide Versus Gemcitabine Plus Docetaxel for High-grade Soft Tissue Sarcoma: Japan Clinical Oncology Group Study JCOG1306

✍ Kataoka, K.; Tanaka, K.; Mizusawa, J.; Kimura, A.; Hiraga, H.; Kawai, A.; Matsun 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 100 KB

Brostallicin, an agent with potential ac

Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

✍ Michael Leahy; Isabelle Ray-Coquard; Jaap Verweij; Axel Le Cesne; Florence Duffa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Brostallicin versus doxorubicin as first

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study

✍ Gelderblom, H.; Blay, J.Y.; Seddon, B.M.; Leahy, M.; Ray-Coquard, I.; Sleijfer, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 758 KB